Femasys announces ce mark and canadian approval for femvue® mini, a fallopian tube assessment solution

Atlanta, aug. 29, 2024 (globe newswire) -- femasys inc. (nasdaq: femy), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, announces that it has received ce mark certification and product approval from health canada, the public health agency of canada, for its compact, eco-friendly femvue® mini for fallopian tube assessment.
FEMY Ratings Summary
FEMY Quant Ranking